Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Intravenous Human Immunoglobulin Market Growth 2022-2028

  • LP 4934027
  • 106 Pages
  • March 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Intravenous Human Immunoglobulin will have significant change from previous year. According to our (LP Information) latest study, the global Intravenous Human Immunoglobulin market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Intravenous Human Immunoglobulin market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Intravenous Human Immunoglobulin market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Intravenous Human Immunoglobulin market, reaching US$ million by the year 2028. As for the Europe Intravenous Human Immunoglobulin landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Intravenous Human Immunoglobulin players cover Baxter, Grifols, CSL, and Octapharma, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Intravenous Human Immunoglobulin market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

Liquid

Powder

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Hospital

Specialty Clinic

Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

Baxter

Grifols

CSL

Octapharma

Biotest

Kedrion

Hualan Bio

CNBG

Shanghai RAAS

CBPO

LFB Group

BPL

Tiantan Biological(Sinopharm)

Taibang Biologic Group

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Intravenous Human Immunoglobulin Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Intravenous Human Immunoglobulin by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Intravenous Human Immunoglobulin by Country/Region, 2017, 2022 & 2028

2.2 Intravenous Human Immunoglobulin Segment by Type

2.2.1 Liquid

2.2.2 Powder

2.3 Intravenous Human Immunoglobulin Sales by Type

2.3.1 Global Intravenous Human Immunoglobulin Sales Market Share by Type (2017-2022)

2.3.2 Global Intravenous Human Immunoglobulin Revenue and Market Share by Type (2017-2022)

2.3.3 Global Intravenous Human Immunoglobulin Sale Price by Type (2017-2022)

2.4 Intravenous Human Immunoglobulin Segment by Application

2.4.1 Hospital

2.4.2 Specialty Clinic

2.4.3 Others

2.5 Intravenous Human Immunoglobulin Sales by Application

2.5.1 Global Intravenous Human Immunoglobulin Sale Market Share by Application (2017-2022)

2.5.2 Global Intravenous Human Immunoglobulin Revenue and Market Share by Application (2017-2022)

2.5.3 Global Intravenous Human Immunoglobulin Sale Price by Application (2017-2022)

3 Global Intravenous Human Immunoglobulin by Company

3.1 Global Intravenous Human Immunoglobulin Breakdown Data by Company

3.1.1 Global Intravenous Human Immunoglobulin Annual Sales by Company (2020-2022)

3.1.2 Global Intravenous Human Immunoglobulin Sales Market Share by Company (2020-2022)

3.2 Global Intravenous Human Immunoglobulin Annual Revenue by Company (2020-2022)

3.2.1 Global Intravenous Human Immunoglobulin Revenue by Company (2020-2022)

3.2.2 Global Intravenous Human Immunoglobulin Revenue Market Share by Company (2020-2022)

3.3 Global Intravenous Human Immunoglobulin Sale Price by Company

3.4 Key Manufacturers Intravenous Human Immunoglobulin Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Intravenous Human Immunoglobulin Product Location Distribution

3.4.2 Players Intravenous Human Immunoglobulin Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Intravenous Human Immunoglobulin by Geographic Region

4.1 World Historic Intravenous Human Immunoglobulin Market Size by Geographic Region (2017-2022)

4.1.1 Global Intravenous Human Immunoglobulin Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Intravenous Human Immunoglobulin Annual Revenue by Geographic Region

4.2 World Historic Intravenous Human Immunoglobulin Market Size by Country/Region (2017-2022)

4.2.1 Global Intravenous Human Immunoglobulin Annual Sales by Country/Region (2017-2022)

4.2.2 Global Intravenous Human Immunoglobulin Annual Revenue by Country/Region

4.3 Americas Intravenous Human Immunoglobulin Sales Growth

4.4 APAC Intravenous Human Immunoglobulin Sales Growth

4.5 Europe Intravenous Human Immunoglobulin Sales Growth

4.6 Middle East & Africa Intravenous Human Immunoglobulin Sales Growth

5 Americas

5.1 Americas Intravenous Human Immunoglobulin Sales by Country

5.1.1 Americas Intravenous Human Immunoglobulin Sales by Country (2017-2022)

5.1.2 Americas Intravenous Human Immunoglobulin Revenue by Country (2017-2022)

5.2 Americas Intravenous Human Immunoglobulin Sales by Type

5.3 Americas Intravenous Human Immunoglobulin Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Intravenous Human Immunoglobulin Sales by Region

6.1.1 APAC Intravenous Human Immunoglobulin Sales by Region (2017-2022)

6.1.2 APAC Intravenous Human Immunoglobulin Revenue by Region (2017-2022)

6.2 APAC Intravenous Human Immunoglobulin Sales by Type

6.3 APAC Intravenous Human Immunoglobulin Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Intravenous Human Immunoglobulin by Country

7.1.1 Europe Intravenous Human Immunoglobulin Sales by Country (2017-2022)

7.1.2 Europe Intravenous Human Immunoglobulin Revenue by Country (2017-2022)

7.2 Europe Intravenous Human Immunoglobulin Sales by Type

7.3 Europe Intravenous Human Immunoglobulin Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Intravenous Human Immunoglobulin by Country

8.1.1 Middle East & Africa Intravenous Human Immunoglobulin Sales by Country (2017-2022)

8.1.2 Middle East & Africa Intravenous Human Immunoglobulin Revenue by Country (2017-2022)

8.2 Middle East & Africa Intravenous Human Immunoglobulin Sales by Type

8.3 Middle East & Africa Intravenous Human Immunoglobulin Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Intravenous Human Immunoglobulin

10.3 Manufacturing Process Analysis of Intravenous Human Immunoglobulin

10.4 Industry Chain Structure of Intravenous Human Immunoglobulin

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Intravenous Human Immunoglobulin Distributors

11.3 Intravenous Human Immunoglobulin Customer

12 World Forecast Review for Intravenous Human Immunoglobulin by Geographic Region

12.1 Global Intravenous Human Immunoglobulin Market Size Forecast by Region

12.1.1 Global Intravenous Human Immunoglobulin Forecast by Region (2023-2028)

12.1.2 Global Intravenous Human Immunoglobulin Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Intravenous Human Immunoglobulin Forecast by Type

12.7 Global Intravenous Human Immunoglobulin Forecast by Application

13 Key Players Analysis

13.1 Baxter

13.1.1 Baxter Company Information

13.1.2 Baxter Intravenous Human Immunoglobulin Product Offered

13.1.3 Baxter Intravenous Human Immunoglobulin Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Baxter Main Business Overview

13.1.5 Baxter Latest Developments

13.2 Grifols

13.2.1 Grifols Company Information

13.2.2 Grifols Intravenous Human Immunoglobulin Product Offered

13.2.3 Grifols Intravenous Human Immunoglobulin Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Grifols Main Business Overview

13.2.5 Grifols Latest Developments

13.3 CSL

13.3.1 CSL Company Information

13.3.2 CSL Intravenous Human Immunoglobulin Product Offered

13.3.3 CSL Intravenous Human Immunoglobulin Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 CSL Main Business Overview

13.3.5 CSL Latest Developments

13.4 Octapharma

13.4.1 Octapharma Company Information

13.4.2 Octapharma Intravenous Human Immunoglobulin Product Offered

13.4.3 Octapharma Intravenous Human Immunoglobulin Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Octapharma Main Business Overview

13.4.5 Octapharma Latest Developments

13.5 Biotest

13.5.1 Biotest Company Information

13.5.2 Biotest Intravenous Human Immunoglobulin Product Offered

13.5.3 Biotest Intravenous Human Immunoglobulin Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Biotest Main Business Overview

13.5.5 Biotest Latest Developments

13.6 Kedrion

13.6.1 Kedrion Company Information

13.6.2 Kedrion Intravenous Human Immunoglobulin Product Offered

13.6.3 Kedrion Intravenous Human Immunoglobulin Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Kedrion Main Business Overview

13.6.5 Kedrion Latest Developments

13.7 Hualan Bio

13.7.1 Hualan Bio Company Information

13.7.2 Hualan Bio Intravenous Human Immunoglobulin Product Offered

13.7.3 Hualan Bio Intravenous Human Immunoglobulin Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Hualan Bio Main Business Overview

13.7.5 Hualan Bio Latest Developments

13.8 CNBG

13.8.1 CNBG Company Information

13.8.2 CNBG Intravenous Human Immunoglobulin Product Offered

13.8.3 CNBG Intravenous Human Immunoglobulin Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 CNBG Main Business Overview

13.8.5 CNBG Latest Developments

13.9 Shanghai RAAS

13.9.1 Shanghai RAAS Company Information

13.9.2 Shanghai RAAS Intravenous Human Immunoglobulin Product Offered

13.9.3 Shanghai RAAS Intravenous Human Immunoglobulin Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Shanghai RAAS Main Business Overview

13.9.5 Shanghai RAAS Latest Developments

13.10 CBPO

13.10.1 CBPO Company Information

13.10.2 CBPO Intravenous Human Immunoglobulin Product Offered

13.10.3 CBPO Intravenous Human Immunoglobulin Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 CBPO Main Business Overview

13.10.5 CBPO Latest Developments

13.11 LFB Group

13.11.1 LFB Group Company Information

13.11.2 LFB Group Intravenous Human Immunoglobulin Product Offered

13.11.3 LFB Group Intravenous Human Immunoglobulin Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 LFB Group Main Business Overview

13.11.5 LFB Group Latest Developments

13.12 BPL

13.12.1 BPL Company Information

13.12.2 BPL Intravenous Human Immunoglobulin Product Offered

13.12.3 BPL Intravenous Human Immunoglobulin Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 BPL Main Business Overview

13.12.5 BPL Latest Developments

13.13 Tiantan Biological(Sinopharm)

13.13.1 Tiantan Biological(Sinopharm) Company Information

13.13.2 Tiantan Biological(Sinopharm) Intravenous Human Immunoglobulin Product Offered

13.13.3 Tiantan Biological(Sinopharm) Intravenous Human Immunoglobulin Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 Tiantan Biological(Sinopharm) Main Business Overview

13.13.5 Tiantan Biological(Sinopharm) Latest Developments

13.14 Taibang Biologic Group

13.14.1 Taibang Biologic Group Company Information

13.14.2 Taibang Biologic Group Intravenous Human Immunoglobulin Product Offered

13.14.3 Taibang Biologic Group Intravenous Human Immunoglobulin Sales, Revenue, Price and Gross Margin (2020-2022)

13.14.4 Taibang Biologic Group Main Business Overview

13.14.5 Taibang Biologic Group Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Intravenous Human Immunoglobulin Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Intravenous Human Immunoglobulin Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Liquid

Table 4. Major Players of Powder

Table 5. Global Intravenous Human Immunoglobulin Sales by Type (2017-2022) & (K Units)

Table 6. Global Intravenous Human Immunoglobulin Sales Market Share by Type (2017-2022)

Table 7. Global Intravenous Human Immunoglobulin Revenue by Type (2017-2022) & ($ million)

Table 8. Global Intravenous Human Immunoglobulin Revenue Market Share by Type (2017-2022)

Table 9. Global Intravenous Human Immunoglobulin Sale Price by Type (2017-2022) & (US$/Unit)

Table 10. Global Intravenous Human Immunoglobulin Sales by Application (2017-2022) & (K Units)

Table 11. Global Intravenous Human Immunoglobulin Sales Market Share by Application (2017-2022)

Table 12. Global Intravenous Human Immunoglobulin Revenue by Application (2017-2022)

Table 13. Global Intravenous Human Immunoglobulin Revenue Market Share by Application (2017-2022)

Table 14. Global Intravenous Human Immunoglobulin Sale Price by Application (2017-2022) & (US$/Unit)

Table 15. Global Intravenous Human Immunoglobulin Sales by Company (2020-2022) & (K Units)

Table 16. Global Intravenous Human Immunoglobulin Sales Market Share by Company (2020-2022)

Table 17. Global Intravenous Human Immunoglobulin Revenue by Company (2020-2022) ($ Millions)

Table 18. Global Intravenous Human Immunoglobulin Revenue Market Share by Company (2020-2022)

Table 19. Global Intravenous Human Immunoglobulin Sale Price by Company (2020-2022) & (US$/Unit)

Table 20. Key Manufacturers Intravenous Human Immunoglobulin Producing Area Distribution and Sales Area

Table 21. Players Intravenous Human Immunoglobulin Products Offered

Table 22. Intravenous Human Immunoglobulin Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 23. New Products and Potential Entrants

Table 24. Mergers & Acquisitions, Expansion

Table 25. Global Intravenous Human Immunoglobulin Sales by Geographic Region (2017-2022) & (K Units)

Table 26. Global Intravenous Human Immunoglobulin Sales Market Share Geographic Region (2017-2022)

Table 27. Global Intravenous Human Immunoglobulin Revenue by Geographic Region (2017-2022) & ($ millions)

Table 28. Global Intravenous Human Immunoglobulin Revenue Market Share by Geographic Region (2017-2022)

Table 29. Global Intravenous Human Immunoglobulin Sales by Country/Region (2017-2022) & (K Units)

Table 30. Global Intravenous Human Immunoglobulin Sales Market Share by Country/Region (2017-2022)

Table 31. Global Intravenous Human Immunoglobulin Revenue by Country/Region (2017-2022) & ($ millions)

Table 32. Global Intravenous Human Immunoglobulin Revenue Market Share by Country/Region (2017-2022)

Table 33. Americas Intravenous Human Immunoglobulin Sales by Country (2017-2022) & (K Units)

Table 34. Americas Intravenous Human Immunoglobulin Sales Market Share by Country (2017-2022)

Table 35. Americas Intravenous Human Immunoglobulin Revenue by Country (2017-2022) & ($ Millions)

Table 36. Americas Intravenous Human Immunoglobulin Revenue Market Share by Country (2017-2022)

Table 37. Americas Intravenous Human Immunoglobulin Sales by Type (2017-2022) & (K Units)

Table 38. Americas Intravenous Human Immunoglobulin Sales Market Share by Type (2017-2022)

Table 39. Americas Intravenous Human Immunoglobulin Sales by Application (2017-2022) & (K Units)

Table 40. Americas Intravenous Human Immunoglobulin Sales Market Share by Application (2017-2022)

Table 41. APAC Intravenous Human Immunoglobulin Sales by Region (2017-2022) & (K Units)

Table 42. APAC Intravenous Human Immunoglobulin Sales Market Share by Region (2017-2022)

Table 43. APAC Intravenous Human Immunoglobulin Revenue by Region (2017-2022) & ($ Millions)

Table 44. APAC Intravenous Human Immunoglobulin Revenue Market Share by Region (2017-2022)

Table 45. APAC Intravenous Human Immunoglobulin Sales by Type (2017-2022) & (K Units)

Table 46. APAC Intravenous Human Immunoglobulin Sales Market Share by Type (2017-2022)

Table 47. APAC Intravenous Human Immunoglobulin Sales by Application (2017-2022) & (K Units)

Table 48. APAC Intravenous Human Immunoglobulin Sales Market Share by Application (2017-2022)

Table 49. Europe Intravenous Human Immunoglobulin Sales by Country (2017-2022) & (K Units)

Table 50. Europe Intravenous Human Immunoglobulin Sales Market Share by Country (2017-2022)

Table 51. Europe Intravenous Human Immunoglobulin Revenue by Country (2017-2022) & ($ Millions)

Table 52. Europe Intravenous Human Immunoglobulin Revenue Market Share by Country (2017-2022)

Table 53. Europe Intravenous Human Immunoglobulin Sales by Type (2017-2022) & (K Units)

Table 54. Europe Intravenous Human Immunoglobulin Sales Market Share by Type (2017-2022)

Table 55. Europe Intravenous Human Immunoglobulin Sales by Application (2017-2022) & (K Units)

Table 56. Europe Intravenous Human Immunoglobulin Sales Market Share by Application (2017-2022)

Table 57. Middle East & Africa Intravenous Human Immunoglobulin Sales by Country (2017-2022) & (K Units)

Table 58. Middle East & Africa Intravenous Human Immunoglobulin Sales Market Share by Country (2017-2022)

Table 59. Middle East & Africa Intravenous Human Immunoglobulin Revenue by Country (2017-2022) & ($ Millions)

Table 60. Middle East & Africa Intravenous Human Immunoglobulin Revenue Market Share by Country (2017-2022)

Table 61. Middle East & Africa Intravenous Human Immunoglobulin Sales by Type (2017-2022) & (K Units)

Table 62. Middle East & Africa Intravenous Human Immunoglobulin Sales Market Share by Type (2017-2022)

Table 63. Middle East & Africa Intravenous Human Immunoglobulin Sales by Application (2017-2022) & (K Units)

Table 64. Middle East & Africa Intravenous Human Immunoglobulin Sales Market Share by Application (2017-2022)

Table 65. Key Market Drivers & Growth Opportunities of Intravenous Human Immunoglobulin

Table 66. Key Market Challenges & Risks of Intravenous Human Immunoglobulin

Table 67. Key Industry Trends of Intravenous Human Immunoglobulin

Table 68. Intravenous Human Immunoglobulin Raw Material

Table 69. Key Suppliers of Raw Materials

Table 70. Intravenous Human Immunoglobulin Distributors List

Table 71. Intravenous Human Immunoglobulin Customer List

Table 72. Global Intravenous Human Immunoglobulin Sales Forecast by Region (2023-2028) & (K Units)

Table 73. Global Intravenous Human Immunoglobulin Sales Market Forecast by Region

Table 74. Global Intravenous Human Immunoglobulin Revenue Forecast by Region (2023-2028) & ($ millions)

Table 75. Global Intravenous Human Immunoglobulin Revenue Market Share Forecast by Region (2023-2028)

Table 76. Americas Intravenous Human Immunoglobulin Sales Forecast by Country (2023-2028) & (K Units)

Table 77. Americas Intravenous Human Immunoglobulin Revenue Forecast by Country (2023-2028) & ($ millions)

Table 78. APAC Intravenous Human Immunoglobulin Sales Forecast by Region (2023-2028) & (K Units)

Table 79. APAC Intravenous Human Immunoglobulin Revenue Forecast by Region (2023-2028) & ($ millions)

Table 80. Europe Intravenous Human Immunoglobulin Sales Forecast by Country (2023-2028) & (K Units)

Table 81. Europe Intravenous Human Immunoglobulin Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. Middle East & Africa Intravenous Human Immunoglobulin Sales Forecast by Country (2023-2028) & (K Units)

Table 83. Middle East & Africa Intravenous Human Immunoglobulin Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Global Intravenous Human Immunoglobulin Sales Forecast by Type (2023-2028) & (K Units)

Table 85. Global Intravenous Human Immunoglobulin Sales Market Share Forecast by Type (2023-2028)

Table 86. Global Intravenous Human Immunoglobulin Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 87. Global Intravenous Human Immunoglobulin Revenue Market Share Forecast by Type (2023-2028)

Table 88. Global Intravenous Human Immunoglobulin Sales Forecast by Application (2023-2028) & (K Units)

Table 89. Global Intravenous Human Immunoglobulin Sales Market Share Forecast by Application (2023-2028)

Table 90. Global Intravenous Human Immunoglobulin Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 91. Global Intravenous Human Immunoglobulin Revenue Market Share Forecast by Application (2023-2028)

Table 92. Baxter Basic Information, Intravenous Human Immunoglobulin Manufacturing Base, Sales Area and Its Competitors

Table 93. Baxter Intravenous Human Immunoglobulin Product Offered

Table 94. Baxter Intravenous Human Immunoglobulin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 95. Baxter Main Business

Table 96. Baxter Latest Developments

Table 97. Grifols Basic Information, Intravenous Human Immunoglobulin Manufacturing Base, Sales Area and Its Competitors

Table 98. Grifols Intravenous Human Immunoglobulin Product Offered

Table 99. Grifols Intravenous Human Immunoglobulin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 100. Grifols Main Business

Table 101. Grifols Latest Developments

Table 102. CSL Basic Information, Intravenous Human Immunoglobulin Manufacturing Base, Sales Area and Its Competitors

Table 103. CSL Intravenous Human Immunoglobulin Product Offered

Table 104. CSL Intravenous Human Immunoglobulin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 105. CSL Main Business

Table 106. CSL Latest Developments

Table 107. Octapharma Basic Information, Intravenous Human Immunoglobulin Manufacturing Base, Sales Area and Its Competitors

Table 108. Octapharma Intravenous Human Immunoglobulin Product Offered

Table 109. Octapharma Intravenous Human Immunoglobulin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 110. Octapharma Main Business

Table 111. Octapharma Latest Developments

Table 112. Biotest Basic Information, Intravenous Human Immunoglobulin Manufacturing Base, Sales Area and Its Competitors

Table 113. Biotest Intravenous Human Immunoglobulin Product Offered

Table 114. Biotest Intravenous Human Immunoglobulin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 115. Biotest Main Business

Table 116. Biotest Latest Developments

Table 117. Kedrion Basic Information, Intravenous Human Immunoglobulin Manufacturing Base, Sales Area and Its Competitors

Table 118. Kedrion Intravenous Human Immunoglobulin Product Offered

Table 119. Kedrion Intravenous Human Immunoglobulin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 120. Kedrion Main Business

Table 121. Kedrion Latest Developments

Table 122. Hualan Bio Basic Information, Intravenous Human Immunoglobulin Manufacturing Base, Sales Area and Its Competitors

Table 123. Hualan Bio Intravenous Human Immunoglobulin Product Offered

Table 124. Hualan Bio Intravenous Human Immunoglobulin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 125. Hualan Bio Main Business

Table 126. Hualan Bio Latest Developments

Table 127. CNBG Basic Information, Intravenous Human Immunoglobulin Manufacturing Base, Sales Area and Its Competitors

Table 128. CNBG Intravenous Human Immunoglobulin Product Offered

Table 129. CNBG Intravenous Human Immunoglobulin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 130. CNBG Main Business

Table 131. CNBG Latest Developments

Table 132. Shanghai RAAS Basic Information, Intravenous Human Immunoglobulin Manufacturing Base, Sales Area and Its Competitors

Table 133. Shanghai RAAS Intravenous Human Immunoglobulin Product Offered

Table 134. Shanghai RAAS Intravenous Human Immunoglobulin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 135. Shanghai RAAS Main Business

Table 136. Shanghai RAAS Latest Developments

Table 137. CBPO Basic Information, Intravenous Human Immunoglobulin Manufacturing Base, Sales Area and Its Competitors

Table 138. CBPO Intravenous Human Immunoglobulin Product Offered

Table 139. CBPO Intravenous Human Immunoglobulin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 140. CBPO Main Business

Table 141. CBPO Latest Developments

Table 142. LFB Group Basic Information, Intravenous Human Immunoglobulin Manufacturing Base, Sales Area and Its Competitors

Table 143. LFB Group Intravenous Human Immunoglobulin Product Offered

Table 144. LFB Group Intravenous Human Immunoglobulin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 145. LFB Group Main Business

Table 146. LFB Group Latest Developments

Table 147. BPL Basic Information, Intravenous Human Immunoglobulin Manufacturing Base, Sales Area and Its Competitors

Table 148. BPL Intravenous Human Immunoglobulin Product Offered

Table 149. BPL Intravenous Human Immunoglobulin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 150. BPL Main Business

Table 151. BPL Latest Developments

Table 152. Tiantan Biological(Sinopharm) Basic Information, Intravenous Human Immunoglobulin Manufacturing Base, Sales Area and Its Competitors

Table 153. Tiantan Biological(Sinopharm) Intravenous Human Immunoglobulin Product Offered

Table 154. Tiantan Biological(Sinopharm) Intravenous Human Immunoglobulin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 155. Tiantan Biological(Sinopharm) Main Business

Table 156. Tiantan Biological(Sinopharm) Latest Developments

Table 157. Taibang Biologic Group Basic Information, Intravenous Human Immunoglobulin Manufacturing Base, Sales Area and Its Competitors

Table 158. Taibang Biologic Group Intravenous Human Immunoglobulin Product Offered

Table 159. Taibang Biologic Group Intravenous Human Immunoglobulin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 160. Taibang Biologic Group Main Business

Table 161. Taibang Biologic Group Latest Developments

List of Figures

Figure 1. Picture of Intravenous Human Immunoglobulin

Figure 2. Intravenous Human Immunoglobulin Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Intravenous Human Immunoglobulin Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Intravenous Human Immunoglobulin Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Intravenous Human Immunoglobulin Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Liquid

Figure 10. Product Picture of Powder

Figure 11. Global Intravenous Human Immunoglobulin Sales Market Share by Type in 2021

Figure 12. Global Intravenous Human Immunoglobulin Revenue Market Share by Type (2017-2022)

Figure 13. Intravenous Human Immunoglobulin Consumed in Hospital

Figure 14. Global Intravenous Human Immunoglobulin Market: Hospital (2017-2022) & (K Units)

Figure 15. Intravenous Human Immunoglobulin Consumed in Specialty Clinic

Figure 16. Global Intravenous Human Immunoglobulin Market: Specialty Clinic (2017-2022) & (K Units)

Figure 17. Intravenous Human Immunoglobulin Consumed in Others

Figure 18. Global Intravenous Human Immunoglobulin Market: Others (2017-2022) & (K Units)

Figure 19. Global Intravenous Human Immunoglobulin Sales Market Share by Application (2017-2022)

Figure 20. Global Intravenous Human Immunoglobulin Revenue Market Share by Application in 2021

Figure 21. Intravenous Human Immunoglobulin Revenue Market by Company in 2021 ($ Million)

Figure 22. Global Intravenous Human Immunoglobulin Revenue Market Share by Company in 2021

Figure 23. Global Intravenous Human Immunoglobulin Sales Market Share by Geographic Region (2017-2022)

Figure 24. Global Intravenous Human Immunoglobulin Revenue Market Share by Geographic Region in 2021

Figure 25. Global Intravenous Human Immunoglobulin Sales Market Share by Region (2017-2022)

Figure 26. Global Intravenous Human Immunoglobulin Revenue Market Share by Country/Region in 2021

Figure 27. Americas Intravenous Human Immunoglobulin Sales 2017-2022 (K Units)

Figure 28. Americas Intravenous Human Immunoglobulin Revenue 2017-2022 ($ Millions)

Figure 29. APAC Intravenous Human Immunoglobulin Sales 2017-2022 (K Units)

Figure 30. APAC Intravenous Human Immunoglobulin Revenue 2017-2022 ($ Millions)

Figure 31. Europe Intravenous Human Immunoglobulin Sales 2017-2022 (K Units)

Figure 32. Europe Intravenous Human Immunoglobulin Revenue 2017-2022 ($ Millions)

Figure 33. Middle East & Africa Intravenous Human Immunoglobulin Sales 2017-2022 (K Units)

Figure 34. Middle East & Africa Intravenous Human Immunoglobulin Revenue 2017-2022 ($ Millions)

Figure 35. Americas Intravenous Human Immunoglobulin Sales Market Share by Country in 2021

Figure 36. Americas Intravenous Human Immunoglobulin Revenue Market Share by Country in 2021

Figure 37. United States Intravenous Human Immunoglobulin Revenue Growth 2017-2022 ($ Millions)

Figure 38. Canada Intravenous Human Immunoglobulin Revenue Growth 2017-2022 ($ Millions)

Figure 39. Mexico Intravenous Human Immunoglobulin Revenue Growth 2017-2022 ($ Millions)

Figure 40. Brazil Intravenous Human Immunoglobulin Revenue Growth 2017-2022 ($ Millions)

Figure 41. APAC Intravenous Human Immunoglobulin Sales Market Share by Region in 2021

Figure 42. APAC Intravenous Human Immunoglobulin Revenue Market Share by Regions in 2021

Figure 43. China Intravenous Human Immunoglobulin Revenue Growth 2017-2022 ($ Millions)

Figure 44. Japan Intravenous Human Immunoglobulin Revenue Growth 2017-2022 ($ Millions)

Figure 45. South Korea Intravenous Human Immunoglobulin Revenue Growth 2017-2022 ($ Millions)

Figure 46. Southeast Asia Intravenous Human Immunoglobulin Revenue Growth 2017-2022 ($ Millions)

Figure 47. India Intravenous Human Immunoglobulin Revenue Growth 2017-2022 ($ Millions)

Figure 48. Australia Intravenous Human Immunoglobulin Revenue Growth 2017-2022 ($ Millions)

Figure 49. Europe Intravenous Human Immunoglobulin Sales Market Share by Country in 2021

Figure 50. Europe Intravenous Human Immunoglobulin Revenue Market Share by Country in 2021

Figure 51. Germany Intravenous Human Immunoglobulin Revenue Growth 2017-2022 ($ Millions)

Figure 52. France Intravenous Human Immunoglobulin Revenue Growth 2017-2022 ($ Millions)

Figure 53. UK Intravenous Human Immunoglobulin Revenue Growth 2017-2022 ($ Millions)

Figure 54. Italy Intravenous Human Immunoglobulin Revenue Growth 2017-2022 ($ Millions)

Figure 55. Russia Intravenous Human Immunoglobulin Revenue Growth 2017-2022 ($ Millions)

Figure 56. Middle East & Africa Intravenous Human Immunoglobulin Sales Market Share by Country in 2021

Figure 57. Middle East & Africa Intravenous Human Immunoglobulin Revenue Market Share by Country in 2021

Figure 58. Egypt Intravenous Human Immunoglobulin Revenue Growth 2017-2022 ($ Millions)

Figure 59. South Africa Intravenous Human Immunoglobulin Revenue Growth 2017-2022 ($ Millions)

Figure 60. Israel Intravenous Human Immunoglobulin Revenue Growth 2017-2022 ($ Millions)

Figure 61. Turkey Intravenous Human Immunoglobulin Revenue Growth 2017-2022 ($ Millions)

Figure 62. GCC Country Intravenous Human Immunoglobulin Revenue Growth 2017-2022 ($ Millions)

Figure 63. Manufacturing Cost Structure Analysis of Intravenous Human Immunoglobulin in 2021

Figure 64. Manufacturing Process Analysis of Intravenous Human Immunoglobulin

Figure 65. Industry Chain Structure of Intravenous Human Immunoglobulin

Figure 66. Channels of Distribution

Figure 67. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390